1. Home
  2. OPAL vs MDXH Comparison

OPAL vs MDXH Comparison

Compare OPAL & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPAL Fuels Inc.

OPAL

OPAL Fuels Inc.

HOLD

Current Price

$2.27

Market Cap

78.3M

Sector

Utilities

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.37

Market Cap

167.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPAL
MDXH
Founded
1998
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Natural Gas Distribution
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
78.3M
167.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
OPAL
MDXH
Price
$2.27
$3.37
Analyst Decision
Sell
Strong Buy
Analyst Count
4
3
Target Price
$2.81
$7.67
AVG Volume (30 Days)
199.2K
124.2K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$329,243,000.00
$103,069,000.00
Revenue This Year
$17.15
$23.34
Revenue Next Year
$22.04
$22.98
P/E Ratio
$91.06
N/A
Revenue Growth
7.26
21.68
52 Week Low
$1.26
$1.35
52 Week High
$4.08
$5.33

Technical Indicators

Market Signals
Indicator
OPAL
MDXH
Relative Strength Index (RSI) 47.11 44.78
Support Level $2.50 $3.11
Resistance Level $2.74 $3.40
Average True Range (ATR) 0.18 0.17
MACD -0.04 0.01
Stochastic Oscillator 36.73 46.88

Price Performance

Historical Comparison
OPAL
MDXH

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: